Ask Our Experts March 7, 2024 Gene editing-based therapies could revolutionize how genetic diseases are treated Patients with the debilitating, inherited blood disorders sickle cell anemia and beta-thalassemia recently received news of a life-changing treatment. The FDA approved Casgevy, a groundbreaking therapy that uses a gene editing tool called CRISPR (pronounced ‘crisper’) to treat these disorders. This is the first ever approval for this innovative type of treatment, which can change the DNA code in a patient’s cells to target the underlying cause of a disease. Read More
Ask Our Experts March 7, 2024 What to know about measles outbreak in the U.S. Measles cases are on the rise globally, despite the availability of a safe and effective vaccine that prevents the infection. In the U.K., where over 400 cases have been detected since October of 2023,1 the alarming surge has been deemed a “national incident.” As a result, the U.S. Centers for Disease Control (CDC) issued a warning for physicians to be on alert for measles cases. Read More
Ask Our Experts March 7, 2024 Raising awareness of a rare type of stroke The American Heart Association (AHA) recently released new analysis and recommendations for the diagnosis and treatment of a rare type of stroke, called cerebral venous thrombosis (CVT).1 CVT makes up just 3% … Read More
Ask Our Experts March 7, 2024 Early cancer detection is paramount in the relentless battle against cancer Recent findings from the American Cancer Society’s latest 2024 Cancer Statistics report paint a complex picture: while overall cancer mortality rates are on a promising decline, the landscape is marred by a … Read More
Podcasts February 15, 2024 Securing top-quality medical care for family members with Leslie Michelson Leslie Michelson, Chairman and Co-Founder of PHM, has over five decades of experience navigating our fragmented healthcare systems for individuals, family offices, and employers. In the Family Office Exchange podcast with FOX CEO Peter Moustakerski, Leslie challenges the misconception that access and wealth guarantee the right healthcare. He shares strategies and tools from his best-selling book, "The Patient’s Playbook." Read More
News February 14, 2024 The future of precision cancer therapy might be to try everything This article, published by Nature, references PHM’s case study, published in Frontiers in Oncology, in partnership with SEngine Precision Medicine. The case highlights the use of SEngine’s cutting-edge molecular profiling technology, the … Read More
